These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8329455)

  • 1. Activation of the murine monocyte/macrophage cell line, J774A1 by poly(A).poly(U): I. Binding of poly(A).poly(U) and induction of oligo-2',5'-adenylate synthetase.
    Marin JG; Rodrigue F; Mencia-Huerta JM; Chabrier PE; Braquet P
    Biochim Biophys Acta; 1993 Jul; 1178(1):103-10. PubMed ID: 8329455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of interleukin-6 and interferon-alpha in the poly(A).Poly(U)-induced 2',5'-oligoadenylate synthetase activity in the mouse monocyte-macrophage cell line, J774A1.
    Marin JG; Mencia-Huerta JM; Braquet P; Chabrier PE
    J Interferon Cytokine Res; 1996 Mar; 16(3):251-7. PubMed ID: 8697148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2', 5' oligo (A) synthetase levels in interferon-sensitive or resistant breast cancer cells.
    Kortsaris A
    Microbiologica; 1988 Apr; 11(2):111-7. PubMed ID: 3405096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of double-stranded ribonucleic acid activated protein kinase and 2',5'-oligo(adenylic acid) polymerase by ethidium bromide.
    Baglioni C; Maroney PA
    Biochemistry; 1981 Feb; 20(4):758-62. PubMed ID: 6163449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies.
    Hovanessian AG; Laurent AG; Chebath J; Galabru J; Robert N; Svab J
    EMBO J; 1987 May; 6(5):1273-80. PubMed ID: 2440675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.
    Ohmann HB; Campos M; Griebel PJ; Babiuk LA
    Can J Vet Res; 1989 Apr; 53(2):161-6. PubMed ID: 2713781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of interferon-induced oligo-2',5'-adenylate synthetase induction in persistent infection.
    Fujii N; Kimura K; Murakami T; Indoh T; Ishida S; Fujinaga K; Oguma K
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3071-4. PubMed ID: 1703217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of 2',5' oligo(A) synthetase in Vero cells.
    Lambropoulos AF; Koliais SI
    Microbiologica; 1989 Apr; 12(2):105-11. PubMed ID: 2747549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of poly(A).poly(U) as an adjuvant.
    Hovanessian AG; Galabru J; Rivière Y; Montagnier L
    Immunol Today; 1988 Jun; 9(6):161-2. PubMed ID: 3256321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cyclic AMP and the regulation of 2',5'-oligo(A)-synthetase activity in a mouse fibroblast cell culture].
    Turpaev KT; Itkes AV; Kartasheva ON; Tunitskaia VL; Kafiani KA
    Dokl Akad Nauk SSSR; 1984; 275(5):1231-4. PubMed ID: 6329622
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of oligo-2',5'-adenylate synthetase in human lymphoid cells treated with 5-azacytosine and 5-iododeoxyuridine.
    Fujii N; Oguma K
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2521-6. PubMed ID: 2431103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of human placenta extract on interferon-induced 2'5' A synthetase activity in murine L929 cells.
    Yin YM; Thang DC; Thang MN
    Prog Clin Biol Res; 1985; 202():397-401. PubMed ID: 2421318
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2'5'A synthetase in the bovine system: preliminary characterization.
    Vanden Broecke C; Plasman PO; Hauzeur K; Goossens A; Ligongo G; Piscitelli S; Werenne J
    Prog Clin Biol Res; 1985; 202():339-44. PubMed ID: 2421312
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of 2',5'oligo (A) synthetase in animals bearing Ehrlich ascites tumor cells.
    Galaktidou G; Kortsaris A; Papageorgiou A; Koliais SI
    Microbiologica; 1987 Apr; 10(2):143-50. PubMed ID: 3587063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasoactive intestinal peptide induces 2',5'-oligoadenylate synthetase and antiviral state in cells of HT-29 colonic cancer].
    Chelbi-Alix MK; Boissard C; Rosselin G; Thang MN
    C R Acad Sci III; 1990; 310(5):147-53. PubMed ID: 1690591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of poly(I):poly(C)-binding 50 K protein and 2',5'-oligoadenylate synthetase in interferon-treated mouse L929 cells.
    Sokawa Y
    J Biochem; 1980 Jul; 88(1):159-66. PubMed ID: 6157678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-regulatory functions of interferon induced enzymes: antimitogenic effect of (2'-5')oligo-A, growth-related variations in (2'-5')oligo-A synthetase, and isolation of its mRNA.
    Revel M; Kimchi A; Friedman M; Wolf D; Merlin G; Panet A; Rapoport S; Lapidot Y
    Tex Rep Biol Med; 1981-1982; 41():452-62. PubMed ID: 6189209
    [No Abstract]   [Full Text] [Related]  

  • 19. IFN gamma potentiates the induction of (2-5)A-synthetase in human tumor cells treated with IFN alpha and beta.
    Bruchelt G; Treuner J; Beck J; Schilling F; Koscielniak E; Niethammer D
    Prog Clin Biol Res; 1985; 202():391-5. PubMed ID: 3938546
    [No Abstract]   [Full Text] [Related]  

  • 20. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.